Furthermore, tumor regressions in human CRC cells treated with BATs + LIGHT were similar to LIGHT + ATC treatment, likely due to LIGHT’s ability to increase CD8+ ATC tumor infiltration. The gene discussed is TNFSF14; the disease is colorectal carcinoma.